This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Mania From Dexfenfluramine

Charles L. Bowden and James Dickson, Jr.

Published: December 15, 1997

Article Abstract

Letter to the Editor

Sir: A wide range of medications has been reported to induce
manic episodes. These include stimulant drugs, such as
dextroamphetamine. A drug recently approved for treatment of
obesity, dexfenfluramine, is not reported to have adverse effects
of mania, hypomania, psychosis, or other similar behavioral effects.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 58

Quick Links: Bipolar Disorder , Mood Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...